Skip to content
OpenCapital
Get started

Incyte INCY Enterprise value

Enterprise value at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$158.92B-2.6%
Pfizer logo
PfizerPFE
$222.4B+9.2%
Gilead Sciences logo
Gilead SciencesGILD
$187.53B+19.7%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$622.06B+50.5%
Amgen logo
AmgenAMGN
$246.43B+9.9%
Biogen logo
BiogenBIIB
$30.08B+34.9%

Other financials

Income statement

See full
Revenue$1.3B+20.9%
Gross profit$1.2B+19.2%
Operating income$301.1M+46.8%
Net income$303.3M+91.7%
EPS (diluted)$1.47+83.8%

Balance sheet

See full
Cash & equivalents$3.5B+78.2%
Total debt$39.4M-8.6%
Total equity$5.6B+53.3%
Total assets$7.3B+27.7%

Cash flow

See full
Operating cash flow$369.4M+38.8%
CapEx$1.6M-43.5%
Free cash flow$367.7M+39.7%

Valuation

See full
Market cap$19.78B+59.9%
P/E13.8×-568×
P/S3.7×+0.9×

Profitability

See full
Gross margin92.5%-0.2pp
Operating margin30%+26.1pp
Net margin26.7%+26.2pp

Returns & leverage

See full
Return on equity30.8%+30.4pp
Debt / equity0×0.0×
Current ratio3.7×+1.6×

Where this comes from

Calculated from Incyte’s reported figures.

$18.7Bmarket cap+$39.4Mtotal debt−$3.5Bcash and equivalents=$15.31B

The official record: Incyte’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Incyte's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Incyte's enterprise value?
Incyte (INCY) reported enterprise value of $15.31B in Q1 2026.
How has Incyte's enterprise value changed year-over-year?
Incyte's enterprise value increased by 55.9% year-over-year, from $9.82B to $15.31B.
What is the long-term trend for Incyte's enterprise value?
Over 4 years (2021 to 2025), Incyte's enterprise value has grown at a -3.9% compound annual growth rate (CAGR), from $60.61B to $51.76B.
What does enterprise value mean?
What it would cost to buy the entire business, debt included and cash netted out.
How do you interpret enterprise value?
The capital-structure-neutral valuation base — used in EV/EBITDA and EV/Sales to compare companies with different leverage on a like-for-like footing.
How does enterprise value compare across companies?
Comparable across non-financial companies via the EV multiples it feeds; not used for banks and insurers.